Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.18 USD | -0.87% | +5.76% | -30.37% |
May. 16 | Advanced Oxygen Therapy plans London float - Sky News | AN |
May. 15 | Walgreens to Sell Over-the-Counter Naloxone Anti-Narcotic Spray to Reverse Opioid Overdoses | MT |
Financials (USD)
Sales 2024 * | 145B | Sales 2025 * | 151B | Capitalization | 15.68B |
---|---|---|---|---|---|
Net income 2024 * | -7.16B | Net income 2025 * | 1.82B | EV / Sales 2024 * | 0.16 x |
Net Debt 2024 * | 7.17B | Net Debt 2025 * | 6.78B | EV / Sales 2025 * | 0.15 x |
P/E ratio 2024 * |
-2.18
x | P/E ratio 2025 * |
9.18
x | Employees | 268,500 |
Yield 2024 * |
7.4% | Yield 2025 * |
5.71% | Free-Float | 60.8% |
Latest transcript on Walgreens Boots Alliance, Inc.
1 day | -0.87% | ||
1 week | +5.76% | ||
Current month | +2.54% | ||
1 month | +3.12% | ||
3 months | -17.29% | ||
6 months | -14.33% | ||
Current year | -30.37% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 23-10-22 | |
Manmohan Mahajan
DFI | Director of Finance/CFO | 45 | 16-01-31 |
Stefano Pessina
CHM | Chairman | 83 | 12-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bryan Hanson
BRD | Director/Board Member | 57 | 22-10-26 |
Valerie Jarrett
BRD | Director/Board Member | 67 | 20-10-28 |
Ginger Graham
BRD | Director/Board Member | 68 | 10-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 18.18 | -0.87% | 7,482,647 |
24-05-16 | 18.34 | +2.52% | 7,256,958 |
24-05-15 | 17.89 | -2.51% | 7,951,140 |
24-05-14 | 18.35 | +1.27% | 10,081,909 |
24-05-13 | 18.12 | +5.41% | 17,992,970 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.37% | 15.68B | |
-22.51% | 12.39B | |
-22.88% | 6.74B | |
-6.01% | 6.29B | |
+11.76% | 6.26B | |
+70.00% | 4.78B | |
-1.17% | 4.7B | |
-5.58% | 4.03B | |
-7.87% | 3.62B | |
-6.67% | 3.06B |
- Stock Market
- Equities
- WBA Stock